CBD Dosage for Anxiety After 50: Why No Proven Consumer Dose Exists
Is there a proven CBD dose for anxiety?
The sources checked here do not establish a safe, effective dose of retail CBD for anxiety--whether for adults over 50 or another group. This page cannot provide a personal amount or schedule. A dose from a research experiment or prescription medicine should not be copied for a store-bought oil, gummy, or capsule.
What the small study can--and cannot--tell us
NCCIH describes a study of 24 people with social anxiety disorder who took CBD or placebo before a simulated public-speaking test. NCCIH characterizes the human evidence for anxiety as small. That one narrow experiment does not establish treatment effectiveness for anxiety disorders generally, long-term safety, or a consumer CBD dosage. The cited evidence is not specific to adults over 50.
Why product and medication details matter
FDA says unapproved CBD products have not been evaluated by the agency to establish whether they treat a condition, an appropriate dose, how they interact with other medicines, or other safety concerns. FDA also identifies potential liver injury and medicine interactions based on evidence from the approved prescription CBD drug. Those findings make medication review important; they do not quantify the risk of every retail product.
Questions to ask
- What diagnosis or factors could be driving my anxiety symptoms?
- What treatments have evidence for my specific situation?
- Could CBD affect my current medicines, supplements, alertness, or liver monitoring?
- What information about a product would be needed to evaluate it?
Do not stop or replace prescribed treatment based on this page. Ask a clinician or pharmacist before combining CBD with medicines or supplements.
For the wider evidence and mental-health risks, see Cannabis and anxiety after 50.
Sources
- NCCIH: Cannabis, marijuana, and cannabinoids -- scope and limits of anxiety evidence.
- FDA: CBD consumer update -- dose/effectiveness uncertainty for unapproved CBD products, liver risk, and interactions.
- FDA: Regulation of cannabis and cannabis-derived products -- U.S. approval context.
These are U.S. sources and not individualized medical or legal advice. Local product rules vary.